Find the latest Breast Cancer news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
FDA approves Datroway for advanced breast cancer The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer. January 21, 2025 2 min read Save Trial of vaccine for triple-negative breast cancer yields ‘encouraging’ results ...
News & Views24 Jan 2025Nature Cancer P: 1-2 Menstrual cycle linked to breast cancer chemotherapy response According to preclinical studies and a retrospective clinical analysis, the menstrual cycle may influence the breast cancer response to neoadjuvant chemotherapy — suggesting that treatment could be...
North America leads the global breast cancer therapeutics market, with an estimated market share of 41.2% in 2024, driven by advanced healthcare infrastructure, high breast cancer incidence, early adoption of innovative the...
By Ryan Scott February 4th 2025 Strutting Into Year 11 With Metastatic Breast Cancer By Martha Carlson January 31st 2025 Itovebi-Based Treatment Has OS Benefit in PIK3CA+ HR+/HER2– Breast Cancer By Ryan Scott January 30th 2025 More News ...
Dec 9, 2024 0 0 Oncology & Cancer Estrous rhythm found crucial for optimizing breast cancer therapy The Netherlands Cancer Institute has found that the estrous cycle stage significantly influences mammary tumors' sensitivity to chemotherapy. In mouse models of breast cancer, treatment initiated during...
At ASCO 2024, Avan J. Armaghani, MD, highlights two key presentations. First, a retrospective study on adjuvant endocrine therapy in ER-low breast cancer (1%-10% ER-positivity) demonstrated that patients who skipped this therapy had significantly worse overall survival, especially those who receiv...
In February 2024, the agent was granted fast track designation from the FDA as a monotherapy for the treatment of adult patients with ER+/HER2- locally advanced or metastatic breast cancer that received prior treatment with endocrine-based therapy. Neoadjuvant/Adjuvant Pembrolizumab Improves Survival ...
Breast cancer treatment newsRecommends lumpectomy, a kind of treatment against breast cancer. Percentage rate of lumpectomy patients of age 35 and younger that are found to be tumor-free; Why lumpectomy treatment was successful 92 percent of the time...
/PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer...